SimBioSys, Mayo Clinic partner to develop AI-powered solutions for cancer patients
The collaboration is aimed at creating cloud-based clinical software tools that facilitate comprehensive decision-making for early-stage breast cancer…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Jan 24
The collaboration is aimed at creating cloud-based clinical software tools that facilitate comprehensive decision-making for early-stage breast cancer…
03 Jan 24
Issuance of U.S. Patent No. 11,850,053 also covers a novel system and method for calculating accurate, real-time heart…
02 Jan 24
José Seripieri Filho, the founder and former CEO of health insurance firm Qualicorp, will acquire UnitedHealth’s Brazilian health…
02 Jan 24
The late-stage multi-centre, randomised, double-masked, placebo-controlled trial will evaluate the safety and effectiveness of ST-100 ophthalmic solution in…
02 Jan 24
According to an interim analysis, healthy individuals aged 40 years and above showed an overall favourable safety and…
29 Dec 23
HOC will expand its metaverse platform to Kazakhstan, Colombia, and other Latin American countries in 2024, and introduce…
26 Dec 23
Karuna is a biopharmaceutical firm focused on the discovery, development and delivery of transformative medicines for individuals with…
22 Dec 23
The authorisation was based on the findings from the Phase 3 SOLSTICE trial in which Livtencity was found…
21 Dec 23
OCE-205 is a therapeutic peptide with a differentiated mechanism of action, designed to relieve portal hypertension while offering…
21 Dec 23
Palatin's focus is solely on its development and clinical pipeline based on the melanocortin receptor system